# Vevye + Flarex Combination Therapy for Dry Eye

> **NCT07553455** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Canyon City Eyecare** · enrollment: 60 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Vevye(Cyclosporine 0.1% Ophthalmic Solution)
- **DRUG:** Flarex

## Key facts

- **NCT ID:** NCT07553455
- **Lead sponsor:** Canyon City Eyecare
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-04-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553455, "Vevye + Flarex Combination Therapy for Dry Eye". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07553455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*